Orthofix Medical Inc. (OFIX)
USD 17.53
(-2.23%)
USD 17.53
(-2.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -45.75 Million | -11.53 Million | 18.47 Million | 74.27 Million | 32.03 Million | 49.91 Million |
| Net Income | -151.39 Million | -19.74 Million | -38.37 Million | 2.51 Million | -28.46 Million | 13.81 Million |
| Depreciation & Amortization | 53.06 Million | 32.07 Million | 33.09 Million | 34.27 Million | 24.69 Million | 18.65 Million |
| Deferred income taxes | 579 Thousand | 314 Thousand | 24.48 Million | 10.78 Million | 1.39 Million | -2.66 Million |
| Stock-based compensation | 35.7 Million | 18.44 Million | 15.43 Million | 16.2 Million | 21.54 Million | 18.93 Million |
| Change in working capital | -53.96 Million | -29.23 Million | -18.1 Million | 19.69 Million | -29.37 Million | -6.99 Million |
| Other non-cash items | 70.25 Million | -13.38 Million | 1.94 Million | -9.21 Million | 42.24 Million | 8.17 Million |
| Investing Cash Flow | -33.13 Million | -24.53 Million | -23.01 Million | -52.33 Million | -22.92 Million | -60.99 Million |
| Investments in PPE | -62.05 Million | -23.16 Million | -19.59 Million | -17.09 Million | -20.52 Million | -15.25 Million |
| Acquisitions | 29.41 Million | -1.5 Million | - | -18 Million | - | -44.29 Million |
| Investment purchases | - | - | -2.17 Million | -10 Million | - | - |
| Sales/Maturities of investments | - | - | - | 17.09 Million | - | - |
| Other Investing Activities | -500 Thousand | 126 Thousand | -1.25 Million | -24.33 Million | -2.4 Million | -1.44 Million |
| Financing Cash Flow | 65.32 Million | -78 Thousand | -3.62 Million | 3.24 Million | -10.68 Million | 2.99 Million |
| Debt repayment | -67.94 Million | -2.59 Million | -537 Thousand | -100.32 Million | -365 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.39 Million | -1.72 Million | -2.55 Million | -2.49 Million | -5.19 Million | -3.42 Million |
| Common Stock Issuance | 5.12 Million | 4.33 Million | 8.82 Million | 7.59 Million | 11.55 Million | 7.1 Million |
| Other Financing Activities | -7.75 Million | -1.82 Million | -6.79 Million | 100.95 Million | -11.48 Million | -4.1 Million |
| Accounts receivables | -10.41 Million | -6.73 Million | -7.04 Million | 13.28 Million | -11.03 Million | -3.7 Million |
| Accounts payables | 8.64 Million | 2.28 Million | 4.25 Million | 2.53 Million | 2.13 Million | -170 Thousand |
| Inventory | -58.05 Million | -18.13 Million | 619 Thousand | -873 Thousand | -5.71 Million | 9.69 Million |
| Other working capital | 5.85 Million | -6.64 Million | -15.92 Million | 4.75 Million | -14.76 Million | -12.82 Million |
| Cash at beginning of period | 50.7 Million | 87.84 Million | 96.82 Million | 70.4 Million | 72.18 Million | 81.15 Million |
| Cash at end of period | 37.75 Million | 50.7 Million | 87.84 Million | 96.82 Million | 70.4 Million | 72.18 Million |
| Capital Expenditure | -62.05 Million | -23.16 Million | -19.59 Million | -17.09 Million | -20.52 Million | -15.25 Million |
| Effect of forex changes on cash | 619 Thousand | -997 Thousand | -815 Thousand | 1.23 Million | -207 Thousand | -881 Thousand |
| Net cash flow / Change in cash | -12.94 Million | -37.14 Million | -8.97 Million | 26.41 Million | -1.78 Million | -8.96 Million |
| Free Cash Flow | -107.8 Million | -34.69 Million | -1.11 Million | 57.17 Million | 11.5 Million | 34.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -33.44 Million | -36.02 Million | -151.39 Million | -22.17 Million | -28.85 Million | -39.42 Million |
| Depreciation & Amortization | 14.03 Million | 14.86 Million | 53.06 Million | 13.96 Million | 14.28 Million | 14.95 Million |
| Deferred income taxes | 767.28 Thousand | 408 Thousand | 579 Thousand | -579.77 Thousand | 333 Thousand | 436 Thousand |
| Stock-based compensation | 9.95 Million | 8.8 Million | 35.7 Million | 3.16 Million | 6.27 Million | 13.24 Million |
| Change in working capital | -5.05 Million | -21.32 Million | -53.96 Million | -13.87 Million | -7.5 Million | -12.52 Million |
| Other non-cash items | 69.14 Million | 60.14 Million | 70.25 Million | 13.3 Million | 15.94 Million | 17.8 Million |
| Investing Cash Flow | -9.63 Million | -10.86 Million | -33.13 Million | -14.75 Million | -22.34 Million | -12.81 Million |
| Investments in PPE | -9.63 Million | -10.81 Million | -62.05 Million | -14.4 Million | -22.34 Million | -12.81 Million |
| Acquisitions | - | - | 29.41 Million | -352.86 Thousand | -13.23 Thousand | 29.63 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 199.85 | -50 Thousand | -500 Thousand | 5997.00 | 13.23 Thousand | -29.63 Million |
| Financing Cash Flow | 138.35 Thousand | 21.45 Million | 65.32 Million | 25.28 Million | 18.25 Million | 5.8 Million |
| Debt repayment | -272.54 Thousand | -24.82 Million | -67.94 Million | -25.33 Million | -18.83 Million | -5.84 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.94 Million | -1.82 Million | -4.39 Million | -1.06 Million | -167 Thousand | -1.2 Million |
| Common Stock Issuance | 3.17 Million | - | 5.12 Million | 2.75 Million | -1069.26 | 2.37 Million |
| Other Financing Activities | -2.76 Million | -3.37 Million | -7.75 Million | -2.8 Million | -586 Thousand | -2.4 Million |
| Accounts receivables | -105.83 Thousand | 813 Thousand | -10.41 Million | -13.28 Million | -2.7 Million | 823 Thousand |
| Accounts payables | -6.65 Million | -820 Thousand | 8.64 Million | 4.32 Million | 2.44 Million | 5.36 Million |
| Inventory | -1.6 Million | -6.93 Million | -58.05 Million | -9.25 Million | -14.99 Million | -16.38 Million |
| Other working capital | 3.29 Million | -14.38 Million | 5.85 Million | 4.34 Million | 7.75 Million | -2.32 Million |
| Cash at beginning of period | 29.46 Million | 37.75 Million | 50.7 Million | 33.66 Million | 37.6 Million | 49.96 Million |
| Cash at end of period | 28.86 Million | 29.46 Million | 37.75 Million | 37.75 Million | 33.66 Million | 37.6 Million |
| Capital Expenditure | -9.63 Million | -10.81 Million | -62.05 Million | -14.4 Million | -22.34 Million | -12.81 Million |
| Effect of forex changes on cash | -91 Thousand | -284 Thousand | 619 Thousand | 561 Thousand | -329 Thousand | 166 Thousand |
| Net cash flow / Change in cash | -598 Thousand | -8.29 Million | -12.94 Million | 4.09 Million | -3.94 Million | -12.36 Million |
| Free Cash Flow | -611.51 Thousand | -29.41 Million | -107.8 Million | -20.6 Million | -21.86 Million | -18.33 Million |
MCS-R
WHA
ANPDY
MCI
SEC
TOELY